Advanced search
Publication Cover
Leukemia & Lymphoma Volume 51, 2010 - Issue 2
Submit an article Journal homepage
357
Views
3
CrossRef citations to date
0
Altmetric
Commentary on selected articles in this issue

Sorafenib – a small molecule with big promise?

Tamar TadmorHematology–Oncology Unit, Bnai-Zion Medical Center, Haifa, IsraelCorrespondence[email protected]
,
Martin S. TallmanFeinberg School of Medicine, Northwestern University, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, USA
&
Aaron PolliackDepartment of Hematology, Hadassah University Hospital, Hebrew University Medical School, Jerusalem, Israel
Pages 181-182 | Published online: 16 Dec 2009

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Fariba Fouladi, Lutz B. Jehn, Stephan K. Metzelder, Florian Hub, Katharina Henkenius, Andreas Burchert, Cornelia Brendel, Thorsten Stiewe & Andreas Neubauer. (2015) Sorafenib induces paradoxical phosphorylation of the extracellular signal-regulated kinase pathway in acute myeloid leukemia cells lacking FLT3-ITD mutation. Leukemia & Lymphoma 56:9, pages 2690-2698.
Read now

Articles from other publishers (2)

Abdullah F. AlAsmari, Nemat Ali, Fawaz AlAsmari, Wael A. AlAnazi, Faleh Alqahtani, Metab Alharbi, Farraj M. Alotaibi, Abdullah A. Aldossari, Mohammed AlSwayyed, Mohammed M. Alanazi & Ali A. Alshamrani. (2020) Elucidation of the Molecular Mechanisms Underlying Sorafenib-Induced Hepatotoxicity. Oxidative Medicine and Cellular Longevity 2020, pages 1-10.
Crossref
Andrzej Lange, Emilia Jaskula, Janusz Lange, Grzegorz Dworacki, Dorota Nowak, Aleksandra Simiczyjew, Monika Mordak-Domagala & Mariola Sedzimirska. (2018) The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow. PLOS ONE 13:1, pages e0190525.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.